Diabetic Risk Score and Fasting Plasma Glucose Testing in the Screening for Type 2 Diabetes Mellitus Risk

Abstract

Type 2 diabetes mellitus (T2DM) is a common metabolic disorder and one of the leading causes of morbidity and mortality in both developed and developing countries. Early recognition and intervention will be helpful in reducing the personal and financial cost of the disease. We used the diabetic risk score (DRS) and fasting plasma glucose test (FPGT) for identification the risk of T2DM. A total of 142 female participants were randomly participated in the present study. These participants were identified as 39 (27.5%) high risk (Gr-III) and 71 (50%) very high risk (Gr-IV) for T2DM groups according to the DRS. In addition with 13 (9.2%) and 2 (1.4%) were newly diagnosed as having HT and T2DM. Both HT and T2DM participants were older than the normal participants. BMI and WC were not significantly different in the comparison of T2DM with Non-T2DM and HT with Non-HT patients. The DRS would be practical to use as tool for T2DM risk screening while FPGT was used to identify impaired fasting glucose and T2DM onset. Then, we recommended FPGT for the individuals with high and very high DRS groups.